Who benefits most from the efficiency advancements though?
Governments seem to benefit most as they effectively determine the margin on testing through regulated pricing. Best example of this being Australian pathology Medicare pricing not changing in 20 years. The company invests in technology to improve efficiency/cost and the public and government mostly reap the rewards. It's a good win for society.
- Forums
- ASX - By Stock
- Ann: Half Yearly Report and Accounts
Who benefits most from the efficiency advancements though?...
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SHL (ASX) to my watchlist
|
|||||
Last
$26.37 |
Change
0.120(0.46%) |
Mkt cap ! $12.66B |
Open | High | Low | Value | Volume |
$26.00 | $26.38 | $25.96 | $31.28M | 1.193M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2895 | $26.37 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$26.38 | 3597 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2895 | 26.370 |
1 | 200 | 26.330 |
6 | 835 | 26.300 |
1 | 5023 | 26.280 |
1 | 151 | 26.270 |
Price($) | Vol. | No. |
---|---|---|
26.400 | 115 | 1 |
26.420 | 5023 | 1 |
26.450 | 5883 | 3 |
26.470 | 5023 | 1 |
26.500 | 5223 | 2 |
Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
Featured News
SHL (ASX) Chart |